Sulforaphane and Curcumin: Two Plant Compounds Geroscience Is Watching
Supplements & Compounds

Sulforaphane and Curcumin: Two Plant Compounds Geroscience Is Watching

A new study suggests sulforaphane sharpens the body's response to exercise in older adults, while a quarter-century of curcumin research keeps circling the same translational wall: bioavailability.

Walk into any serious gym and you'll find guys stacking creatine, whey, and electrolytes like it's a science. Walk into a geroscience lab and you'll find researchers asking a quieter question: which plant compounds actually move the needle on the cellular machinery that drives adaptation and aging? Two molecules keep showing up in that conversation — sulforaphane, the sulfur-rich phytochemical from broccoli sprouts, and curcumin, the yellow pigment in turmeric. Neither is a miracle. Both are interesting. And the newest data is worth a careful look before you reorganize your supplement shelf.

Here's the framing. Exercise is, at the cellular level, a controlled stress. You generate reactive oxygen species, and your cells respond by activating NRF2 — a master transcription factor that turns on antioxidant and detoxification genes. That redox response is a big part of why training makes you more resilient over time. The problem: as people age, that signal gets blunted. The hormetic punch lands softer.

That's the gap a 2025 GeroScience study set out to probe. Researchers recruited 25 older adults — average age 67 — and had them do a 30-minute cycling bout. They drew blood before and immediately after, isolated immune cells (PBMCs), and treated them with or without sulforaphane in a dish. Four conditions: control, sulforaphane alone, exercise alone, and exercise plus sulforaphane. Then they measured NRF2 activation and the downstream antioxidant genes it controls — NQO1, HO-1, GR, GCLC.

All three active conditions beat control. But the combination — acute exercise plus ex vivo sulforaphane — produced the largest NRF2 activation. In other words, in this small mechanistic study, the phytochemical didn't replace the exercise stimulus. It amplified it.

25
older adults studied
67
mean age (years)
30 min
cycling bout used as the in vivo stimulus
5 µM
sulforaphane dose applied ex vivo

Why this matters — and why it doesn't (yet)

Read that paragraph again, because the design is doing a lot of work. The exercise happened in the human. The sulforaphane was added to the cells in a dish afterward. That's an elegant way to isolate mechanism, but it's not the same as proving that swallowing a broccoli-sprout capsule before your next ride will translate into better long-term adaptation. The authors are essentially saying: the biology is plausible, the signal is there, the older-adult redox deficit appears bridgeable. Whether oral sulforaphane in real humans, taken around real training, produces meaningful functional gains — that trial hasn't been run.

This is the part the supplement world routinely skips. A mechanistic win in PBMCs is a green light to keep investigating, not a green light to market.

The phytochemical didn't replace the exercise stimulus. It amplified it.
Older adult cycling in a research lab setting

The study paired a 30-minute cycling bout with cell-level analysis — mechanism first, outcomes later.

Curcumin: 25 years of mechanism, one stubborn problem

Now the turmeric question. A 2025 narrative review in Nutrients synthesizes a quarter-century of work on curcumin and the aging brain — Alzheimer's, Parkinson's, post-stroke cognitive impairment. The mechanistic story is genuinely impressive. Curcumin appears to dampen oxidative stress, suppress inflammatory drivers like NF-κB, COX-2, and iNOS, modulate apoptosis, interfere with amyloid-beta aggregation, and upregulate BDNF — the neurotrophic factor that supports neuronal plasticity. It also touches autophagy and mitophagy, the cellular housekeeping pathways that decline with age.

In rodent models of Alzheimer's, Parkinson's, and ischemic stroke, the review notes dose-dependent neuroprotective effects, with results meaningfully improved when the compound is delivered via nanoparticle-based formulations. That last detail is the catch — and it's a big one.

Curcumin's oral bioavailability is famously poor. The molecule that does beautiful things in a Petri dish or a targeted delivery vehicle struggles to reach the brain in useful concentrations when you eat it. The review is candid about this: clinical translation has been limited precisely because the pharmacokinetics don't cooperate. Standard turmeric powder, even in generous amounts, isn't the same intervention as the engineered formulations producing the preclinical wins.

Turmeric powder and root on a linen surface

Curcumin's mechanistic résumé is long. Its oral bioavailability is the asterisk on every line.

How to think about this on the gym floor

If you're the kind of lifter who reads abstracts, here's the honest synthesis. Sulforaphane has a plausible, mechanistically grounded case as an adjunct to exercise in older adults, supported by a small in vivo–ex vivo human study. Curcumin has 25 years of preclinical neuroprotective mechanism behind it and a real translational ceiling imposed by bioavailability. Neither finding clears the bar for confident clinical recommendations. Both clear the bar for serious continued research.

What it doesn't mean: that capsules can substitute for training, sleep, or protein intake. What it does mean: the food matrix these compounds come from — cruciferous vegetables, turmeric used liberally in cooking — is a low-risk, high-reward dietary choice on its own merits, independent of any supplement marketing claim. Before adding a concentrated extract on top of medications or training plans, talk to a clinician who knows your bloodwork.

Key takeaways
  • Sulforaphane plus exercise > either alone — at least at the level of NRF2 activation in immune cells from older adults, in a small mechanistic study.
  • The exercise was real; the sulforaphane was in a dish. Oral supplementation in training humans hasn't been tested to the same standard.
  • Curcumin's mechanism list is long — anti-inflammatory, anti-amyloid, BDNF-supporting, autophagy-modulating — across AD, PD, and post-stroke models.
  • Bioavailability is the wall. Most preclinical wins rely on engineered delivery, not the turmeric in your spice rack.
  • Evidence rating: Early. Promising biology, limited human outcome data. Eat the vegetables; be skeptical of the capsules.
  • Talk to a clinician before stacking concentrated extracts, especially alongside prescription medications.